As Brazil's economy expands, global companies are playing a larger role in its market development, creating opportunities tied to this growth. This basket offers exposure to US and EU-listed multinationals that have a significant stake in Brazil’s economic expansion.
Published on October 8
These multinational corporations are deeply embedded in Brazil's economy, benefiting directly from the country's expansion through established operations and growing market share.
Foreign investment trends are favouring emerging economies like Brazil, creating significant opportunities for global companies with strategic positions in these markets.
These companies are becoming integral to Brazil's development through strategic partnerships and integration into local supply chains, positioning them for long-term growth.
Brazil's economic expansion is being significantly driven by global corporations deepening their involvement in the country. Foreign investment trends favour emerging economies, and many US and EU-listed multinationals are becoming key economic growth drivers through established operations and strategic integration into local supply chains.
This group focuses on non-Brazilian companies listed on US or EU exchanges that have significant stakes in Brazil's development. These firms span key sectors like consumer staples, technology, and industrials, offering exposure to Brazilian growth without directly investing in Brazilian-listed stocks.
These companies were handpicked because they benefit directly from Brazil's progress through their local operations, growing sales, and strategic partnerships. They represent a unique angle on Brazil's growth story by capturing the international forces behind the country's market cap expansion.
Interpretation of the basket's market capitalization and investor takeaways, following FCA compliance guidance.
MELI: $109.21B
KO: $284.47B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 3.65% over the next year.
2 of 3 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+3.65%
